Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Kendall Company

This article was originally published in The Gray Sheet

Executive Summary

Mansfield, Massachusetts-based Kendall International subsidiary, which supplies wound care, vascular therapy, urological care, anesthetic care and incontinence care products, files statement with the Securities and Exchange Commission related to a proposed offering of $100 mil. in senior subordinated notes due 2003. Net proceeds, "together with additional borrowings" under an amended bank credit agreement, will be used to redeem all of the company's outstanding 10%/12% senior subordinated notes due 2000 "in the principal amount of $195.7 mil." Merrill Lynch & Co. and Citicorp Securities Markets are underwriting.

You may also be interested in...



FDA Overhauls Its Purple Book

The US FDA has overhauled its ‘Purple Book’ to make it a searchable database of biologics information. The agency is also seeking input on next steps.

ICH Syncs Reproductive Toxicity Guidance With Current Science

The International Council for Harmonisation has replaced its 1993 guideline on reproductive toxicity studies with an updated version.

Stada Grabs GSK Brands In EU

Stada says it has become a "major consumer healthcare player" after signing a deal to acquire from GSK 15 brands, which generate annual sales of around €120m.

UsernamePublicRestriction

Register

MT000535

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel